-
Napoli threaten absent Lukaku with disciplinary action
-
German whale saga continues as struggling animal beached again
-
Chelsea's Cucurella laments 'instability' caused by Maresca exit
-
'Iran will be at World Cup' and play in US, FIFA's Infantino tells AFP
-
Stocks rise on peace hopes, oil flat
-
Senegal enacts law doubling penalty for same-sex relations
-
De Zerbi 'agrees in principle' to become new Tottenham boss - reports
-
Trump says other countries should 'just take' the Strait of Hormuz
-
Russian oil tanker docks in Cuba after US blockade relief
-
Next days in Iran war will be 'decisive': Pentagon chief
-
Indonesia rations fuel as prices soar over Mideast war
-
How Middle East war is driving up shipping costs
-
Russian tanker brings oil to Cuba as US eases blockade
-
Asia to be hit hardest by Iran war energy crisis: Kpler to AFP
-
Huawei reports slowing revenue growth in 2025
-
Sexualised deepfakes targeting actress spur German '#MeToo' moment
-
Australia head to World Cup on a high after crushing Curacao 5-1
-
Italy fertility rate fell to new low of 1.14 in 2025
-
Pakistan cricketer Zaman gets two-match PSL ban for ball tampering
-
Oil prices rise, stocks mixed on Iran war uncertainty
-
In Beirut's largest stadium, displaced people with disabilities face 'ordeal'
-
Deposed and detained: Niger president's fate unclear nearly three years on
-
Newcastle say no manager change 'at the moment'
-
Newly-hatched rare Indian bustard chick gets 50-strong guard
-
Stranded whale frees itself again off German coast
-
Archaeologists forced by Mideast war to cut short Iraq digs
-
Stranded whale frees itself again off German coast and disappears
-
Thailand's king endorses new cabinet
-
China bans entombing cremated remains in empty flats
-
Calls grow for 15-year-old Suryavanshi to make India bow
-
Stocks slip, oil swings after report says Trump willing to end war
-
Pakistan cricketer Naseem fined record $71,500 for minister criticism
-
China teen diving prodigy nearly retired after 'reaching mental limit'
-
Myanmar junta chief elected vice-president
-
Russian tanker set to deliver oil to crisis-hit Cuba
-
Iran fires missiles across Middle East as Trump threatens oil hub
-
Indonesia summons Google, Meta for 'not complying' with teen social media ban: minister
-
Wembanyama at the double as Spurs beat Bulls
-
Australia investigates tech giants over social media ban breaches
-
Hindu devotional clubbing sways India's youth
-
Oil slips, stocks rise as report says Trump willing to end war
-
Mind games: How football stars are fuelling chess boom
-
Indonesia trims meals programme: what next?
-
'A very big deal': Canadian astronaut reflects on historic Moon mission
-
US pro table tennis league blasts niche sport into spotlight
-
Iran defiant as Trump threatens to destroy oil island
-
UPDATE: Lt. General (Ret.) Keith Kellogg Joins Powerus Board of Advisors to Shape the Future of U.S. Autonomous Drone Defense
-
Inc. Names iTrustCapital to Its 2026 List of the Fastest-Growing Private Companies in the Pacific
-
HighLevel Ranked No. 13 on Inc.'s 2026 Regionals: Southwest List
-
Centennial and Lincoln Launch "Centennial, powered by Lincoln" National Retail Operating Platform
Court to hear lawsuit seeking to ban abortion pill in US
A Texas judge favored by anti-abortion activists will hear arguments Wednesday in an unprecedented challenge to the legality of a widely-used abortion pill.
US District Court Judge Matthew Kacsmaryk announced Monday the hearing on a lawsuit alleging the US Food and Drug Administration (FDA) should never have approved the "dangerous" prescription drug Mifepristone in 2000.
Mifepristone, one component of a two-drug regimen used for medication abortion, has been used by an estimated 5.6 million women to terminate pregnancies since its approval, according to the FDA.
It is can be used in the United States up to 10 weeks of pregnancy.
The pro-abortion rights Guttmacher Institute estimates that more than half of all abortions involve the use of mifepristone.
But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying its approval "disavow(ed)" science, "ignored" potential health impacts and "disregarded" the complications that can arise with using mifepristone.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Galvanized by the Supreme Court's ruling in June that overturned the constitutional right to an abortion, abortion opponents have now set their sights on obtaining prohibitions on mifepristone.
Already the treatment has been halted in some 15 states which have banned all abortion since the 2022 Supreme Court decision.
The Texas suit seeks to block it nationally by overturning the FDA's approval of the drug.
The FDA has urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
Kacsmaryk was targeted by the plaintiffs to hear the case due to his deep conservative Christian beliefs and previous anti-abortion stance.
He had been expected since February 24 to issue a ruling in the case, which asks him to suspend the FDA's approval of the drug while the lawsuit proceeds.
Apparently fearing protestors descending on the courthouse in Amarillo, Texas, Kacsmaryk originally sought to keep the hearing secret until the last minute, but it leaked to media.
If he does order the suspension, it could leave pregnant women with the alternative of using only misoprostol, the second pill in the medication abortion treatment.
But using misoprostol alone is more physically traumatic than the two-pill procedure, and some fear doctors might be unwilling to prescribe it alone.
If mifepristone is banned, "access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
E.Rodriguez--AT